[1] |
Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies[J]. J Allergy Clin Immunol, 2017,140(3):645⁃653. doi: 10.1016/j.jaci.2017. 07.004.
|
[2] |
Dong J, Yang XF, Wang LX, et al. Modulation of Tim⁃3 expression by antigen⁃dependent and ⁃independent factors on T cells from patients with chronic hepatitis b virus infection[J]. Front Cell Infect Microbiol, 2017,7:98. doi:10.3389/fcimb.2017.00098.
|
[3] |
Huang YH, Zhu C, Kondo Y, et al. CEACAM⁃1 regulates TIM⁃3⁃mediated tolerance and exhaustion[J]. Nature, 2015,517(7534):386⁃390. doi: 10.1038/nature13848.
|
[4] |
Xia Q, Wei L, Zhang Y, et al. Immune checkpoint receptors Tim⁃3 and PD⁃1 regulate monocyte and T lymphocyte function in septic patients[J]. Mediators Inflamm, 2018,2018:1632902. doi: 10.1155/2018/1632902.
|
[5] |
Yi W, Zhang P, Liang Y, et al. T⁃bet⁃mediated Tim⁃3 expression dampens monocyte function during chronic hepatitis C virus infection[J]. Immunology, 2017,150(3):301⁃311. doi: 10.1111/imm.12686.
|
[6] |
Kanai Y, Satoh T, Igawa K, et al. Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis[J]. Acta Derm Venereol, 2012,92(4):367⁃371. doi: 10.2340/00015555-1285.
|
[7] |
中华医学会皮肤性病分会银屑病学组. 中国银屑病治疗专家共识(2014版)[J]. 中华皮肤科杂志, 2014,47(3):213⁃215. doi: 10.3760/cma.j.issn.0412⁃4030.2014.03.017.
|
[8] |
He Y, Cao J, Zhao C, et al. TIM⁃3, a promising target for cancer immunotherapy[J]. Onco Targets Ther, 2018,11:7005⁃7009. doi: 10.2147/OTT.S170385.
|
[9] |
Kanai Y, Satoh T, Igawa K, et al. Impaired expression of Tim⁃3 on Th17 and Th1 cells in psoriasis[J]. Acta Derm Venereol, 2012,92(4):367⁃371. doi: 10.2340/00015555⁃1285.
|
[10] |
Wang Z, Yin N, Zhang Z, et al. Upregulation of T⁃cell immunoglobulin and mucin⁃domain containing⁃3 (Tim⁃3) in monocytes/macrophages associates with gastric cancer progression[J]. Immunol Invest, 2017,46(2):134⁃148. doi: 10. 1080/08820139.2016.1229790.
|
[11] |
Xu C, Ge H, Wang T, et al. Increased expression of T cell immunoglobulin and mucin domain 3 on CD14+ monocytes is associated with systemic inflammatory reaction and brain injury in patients with spontaneous intracerebral hemorrhage[J]. J Stroke Cerebrovas Dis, 2018,27(5):1226⁃1236. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.041.
|
[12] |
Hou N, Jiang N, Zou Y, et al. Down⁃regulation of Tim⁃3 in monocytes and macrophages in plasmodium infection and its association with parasite clearance[J]. Front Microbiol, 2017,8:1431. doi: 10.3389/fmicb.2017.01431.
|
[13] |
Wang J, Li C, Fu J, et al. Tim⁃3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B[J]. Scand J Immunol, 2019:e12755. doi: 10.1111/sji.12755.
|
[14] |
Zhang Y, Ma CJ, Wang JM, et al. Tim⁃3 negatively regulates IL⁃12 expression by monocytes in HCV infection[J]. PLoS One, 2011,6(5):e19664. doi: 10.1371/journal.pone.0019664.
|
[15] |
Jiang X, Zhou T, Xiao Y, et al. Tim⁃3 promotes tumor⁃promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1⁃miR⁃155 signaling axis[J]. Oncoimmunology, 2016,5(9):e1211219. doi: 10.1080/2162402X. 2016.1211219.
|